{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-054273","form_type":"8-K","ticker":"TXG","cik":"0001770787","company_name":"10x Genomics, Inc.","filed_at":"2026-08-06T20:03:51+00:00","discovered_at":"2026-08-06T20:05:01.339228+00:00","generated_at":"2026-08-06T20:05:27.120450+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"10x Genomics Q2 revenue $151M (+3% ex-settlements); raises FY2026 guidance to $610-630M","bullets":["Revenue $151.0M, up 3% YoY excluding patent settlement revenue; gross margin 74% vs 72%.","Operating loss $19.6M vs prior-year operating income $30.1M; net loss $17.9M vs net income $34.5M.","Acquired Proteintech Genomics for protein detection; collaborations with Cleveland Clinic and Lausanne University Hospital.","Raises FY2026 revenue guidance to $610-630M from $600-625M, representing 2-5% growth ex-settlements.","Cash and marketable securities $552.0M as of June 30, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-054273","json":"https://secwatch.observer/filing/0001628280-26-054273.json","markdown":"https://secwatch.observer/filing/0001628280-26-054273.md","text":"https://secwatch.observer/filing/0001628280-26-054273.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770787/000162828026054273/0001628280-26-054273-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770787/000162828026054273/txg-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T20:05:27.120450+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}